On June 25, 2026, Bruce Booth, categorized as "Other" at Kymera Therapeutics, Inc. (KYMR), executed multiple sales of company shares. These transactions totaled approximately $40.19 million across four separate filings.
The sales by Mr. Booth included 112,299 shares at an average price of $120.66 per share, amounting to $13.55 million. He also sold 103,688 shares at $100.42 per share for $10.41 million, 81,500 shares at $116.53 per share for $9.50 million, and 58,205 shares at $115.57 per share, totaling $6.73 million.
These sales by Mr. Booth follow additional significant insider selling activity reported on June 26, 2026. Several entities, including BIOTECHNOLOGY VALUE FUND L P, BVF PARTNERS L P/IL, BVF INC/IL, BIOTECHNOLOGY VALUE